Metrics
Publication
90
Open Access
3
UN Sustainable Development Goals
Education
1994 - 1997
1994 - 1997Doctorate
Imperial College of Science, Technology and Medicine, Biyokimya, Moleküler Biyoloji Ve Genetik, United Kingdom
1983 - 1989
1983 - 1989Undergraduate
Istanbul University, Istanbul Medical Faculty, Turkey
Dissertations
1997
1997Doctorate
Cloning and characterization of the Salmonella typhimurium dehydroquinate synthase
Imperial College of Science, Technology and Medicine, Life Sciences, Biochemistry
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
A2 Elementary
A2 ElementaryGerman
Research Areas
Medicine
Medical Biology
Pharmaceutical Biotechnology
Life Sciences
Molecular Biophysics
Molecular Biochemistry
Molecular Biology and Genetics
Genetic Disorders
Genetic Engineering
Moleculer Biology of Cancer
Health Sciences
Fundamental Medical Sciences
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2019 - Present
2019 - PresentProfessor
Hacettepe University, Sağlık Bilimleri Enstitüsü, Kök Hücre Bilimleri A.B.D.
2012 - 2019
2012 - 2019Associate Professor
Hacettepe University, Sağlık Bilimleri Enstitüsü, Kök Hücre Bilimleri A.B.D.
2010 - 2012
2010 - 2012Associate Professor
Hacettepe University, Çocuk Sağlığı Enstitüsü
2008 - 2010
2008 - 2010Lecturer PhD
Hacettepe University, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
2008 - 2010
2008 - 2010Lecturer PhD
Hacettepe University, Çocuk Sağlığı Enstitüsü
2001 - 2008
2001 - 2008Assistant Professor
Kirikkale University, Faculty of Medicine, Medical Biology and Genetics
1999 - 2000
1999 - 2000Expert PhD
Manisa Celal Bayar University, Faculty of Medicine, Tıbbi Biyoloji ve Genetik
1994 - 1999
1994 - 1999Research Assistant PhD
Manisa Celal Bayar University, Faculty of Medicine, Department of Biophysics
Managerial Experience
2025 - Present
2025 - PresentApplied Research Center Board Member
Hacettepe University, Center for Stem Cell Reseach and Development
2017 - Present
2017 - PresentAcademic Performance D. Board Member
Hacettepe University, Sağlık Bilimleri Enstitüsü, Kök Hücre Bilimleri A.B.D.
2011 - Present
2011 - PresentAcademic Council Member of Department
Hacettepe University, Sağlık Bilimleri Enstitüsü, Kök Hücre Bilimleri A.B.D.
2018 - 2024
2018 - 2024Head of Department
Hacettepe University, Sağlık Bilimleri Enstitüsü, Kök Hücre Bilimleri A.B.D.
2021 - 2022
2021 - 2022Academic Council Member of Department
Hacettepe University, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü
2008 - 2010
2008 - 2010Academic Council Member of Department
Hacettepe University, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
2001 - 2008
2001 - 2008Faculty Academic Council Member
Kirikkale University, Faculty Of Medıcıne, Department Of Basıc Medıcal Scıences
2001 - 2008
2001 - 2008Head of Department
Kirikkale University, Faculty Of Medıcıne, Department Of Medical Biology and Genetics
Non Academic Experience
2024 - Present
2024 - Present'Delivery strategies' Çalışma Grubu üyesi (WG3)
European Union, European Cooperation in Science & Technology, Gene Therapy for the treatment of human Disease Network (GeneHumdi | COST action CA21113), 'Delivery strategies' Çalışma Grubu üyesi (WG3)
2024 - Present
2024 - PresentWorking group member
European Union, European Cooperation in Science & Technology, CA21154 - Translational control in Cancer European Network (TRANSLACORE), Working group member
2022 - Present
2022 - PresentCommission Member
Professional Association, Tıbbi Genetik Derneği, İleri Tedaviler Komisyonu, Commission Member
2009 - 2013
2009 - 2013COST Action BM0805 Management Committee Member
European Union, European Cooperation in Science & Technology , Cost Action BM0805 HOX and TALE transcription factors in Development and Disease , COST Action BM0805 Management Committee Member
1994 - 1997
1994 - 1997PhD candidate
University, University of London, Imperial College Science Technology & Medicine, Biochemistry, PhD candidate
1989 - 1993
1989 - 1993Medical Doctor, General Practioner
Ministry, Sağlık Bakanlığı , Sağlık Ocağı, Medical Doctor, General Practioner
Courses
Doctorate
Doctorate
KÖK HÜCRE BİYOLOJİSİNDE TEMEL MEKANİZMALAR
Kök Hücre Laboratuvar Yöntemleri II
MECMUA KLUBÜ II
Doku ve Organ Kök Hücreleri
Bilimsel Yazım ve Raporlandırma Teknikleri
Kök Hücre Laboratuvar Yöntemleri I
Kök Hücre Bilimlerinde Temel Kavramlar
MECMUA KLUBÜ I
Doktora Yeterlilik Sınavına Hazırlık
Rejeneratif Tıpta Kök Hücre ve Gen Tedavileri
ÖZEL KONULAR
BİLİMSEL YAZIM VE RAPORLANDIRMA TEKNİKLERİ
MECMUA KLUBÜ II
Hematopoez
SEMİNER
Rejeneratif Tıp ve Hücresel Tedaviler
Stem Cell and Gene Therapies
Kök Hücre Transplantasyon Temelleri ve Uygulama İlkeleri
Kalıtsal Hastalıklar ve Deneysel Modellerde Kök Hücre
Postgraduate
Postgraduate
Kök Hücre Yapısının Moleküler Esasları
Gelişimin Temel İlkeleri
Kök Hücrede Biyokimyasal Etkileşimler
Kök Hücre Araştırma Laboratuvarında Temel İlkeler
ÖZEL KONULAR
SEMİNER
Kök Hücre ve Hücresel Tedavi: Temel Kavramlar
Kök Hücrede Biyokimyasal Etkileşimler
Gelişimin Temel İlkeleri
Kök Hücre Laboratuvar Yöntemleri I
Supervised Theses
2024
2024Postgraduate
Hepatosit büyüme faktörü (HGF) ile lisanslanmış mezenkimal kök hücrelerde anti-fibrotik mirna ifade düzeyleri
Özcan A. (Advisor)
A.BERK(Student)
2023
2023Postgraduate
Kemik İliği Mezenkimal Kök Hücrelerinde p53 Yolağı Regülasyonunda PKNOX2 ve Etkileşimlerinin Araştırılması
Özcan A. (Advisor)
M.KELEŞ(Student)
2023
2023Doctorate
Podosit Hasar Modelinde İndüklenmiş Mezenkimal Kök Hücrelerinin Etkisi
Özcan A. (Advisor)
Ö.Burcu(Student)
2022
2022Postgraduate
Gene Expression Omnibus (GEO) Veribankası kaynakları kullanılarak nöral krest kaynaklı dental kök hücrelerinin, nörojenik rejenerasyon ile ilişkili gen ifade profillerinin karşılaştırılmalı olarak incelenmesi
Özcan A. (Advisor)
A.CEVDET(Student)
2021
2021Postgraduate
Mezenkimal Kök Hücre Yaşlanmasında NF-κB/p65 ve PKNOX2 Protein-protein Etkileşimlerinin İncelenmesi
Özcan A. (Advisor)
E.KOÇAK(Student)
2019
2019Postgraduate
Kemik İliği Mezenkimal Kök Hücrelerinde PKNOX2 Proteinin ATM ve RNF8 ile Etkileşimlerinin İncelenmesi
Özcan A. (Advisor)
N.DÖNMEZ(Student)
2018
2018Doctorate
Hox and tale transcription factors in fanconi anemia bone-marrow mesenchymal stem cells: Gene expression and protein interactions
Özcan A. (Advisor)
I.ÇAĞNAN(Student)
2015
2015Doctorate
pGITRL aktarılan mezenkimal kök hücrelerin küçük hücreli akciğer kanserine in vitro etkisi ve altın nanopartiküllerle işaretlenmesi
Özcan A. (Co-Advisor), Korkusuz P.
Ç.ZÜBEYDE(Student)
2006
2006Doctorate
Fare IL-18 veya CD40L genlerini taşıyan rekombinant Salmonella typhimurium aroB suşlarının oluşturulması ve gen tedavisi vektörü olarak değerlendirilmesi
Özcan A. (Co-Advisor), Güç D.
D.AYDIN(Student)
2003
2003Postgraduate
CD40 ligand (CD154) genin ökaryotik ekspresyon vektörüne klonlanması
ÖZCAN A. (Co-Advisor)
G.ESENDAĞLI(Student)
Articles
All (39)
SCI-E, SSCI, AHCI (36)
SCI-E, SSCI, AHCI, ESCI (37)
ESCI (1)
Scopus (37)
TRDizin (2)
Other Publications (2)
2025
20251. HOX and MEINOX in cellular plasticity, fibrosis, and cancer.
Keleş M., Gunel-Ozcan A.
World journal of stem cells
, vol.17, no.9, pp.109102, 2025 (SCI-Expanded, Scopus)
2025
20252. A new CRISPR-mediated Apc knockout allele leads to pyloric gland adenoma-like gastric polyps in mice with C57BL/6;FVB/N mixed background
Uzun S., Ozcan O., Gok A., Isik A., Bakir S., Günel Özcan A., et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE
, 2025 (ESCI, Scopus)
2024
20243. Hypoxia and Hypoxia Mimetic Agents As Potential Priming Approaches to Empower Mesenchymal Stem Cells.
Yasan G. T., Gunel-Ozcan A.
Current stem cell research & therapy
, vol.19, no.1, pp.33-54, 2024 (SCI-Expanded, Scopus)
2022
20224. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients
Cagnan I., Keles M., Keskus A. G., Tombaz M., ŞAHAN Ö. B., AERTS KAYA F. S. F., et al.
HUMAN CELL
, vol.35, no.1, pp.111-124, 2022 (SCI-Expanded, Scopus)
2021
20215. Single dose application IGF-1 and HGF induced bone marrow mesenchymal stem cells reduced proteinuria in focal segmental gomerulosclerosis model
Şahan Ö. B., Onbaşılar İ., Güçer K. Ş., Kaymaz F. F., Atayar E., Özaltın F., et al.
FEBS OPEN BIO
, vol.11, pp.35, 2021 (SCI-Expanded, Scopus)
2021
20216. Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells.
Güney-Esken G., Erol Ö. D., Pervin B., Gürhan Sevinç G., Önder T., Bilgiç E., et al.
Stem cell research & therapy
, vol.12, no.1, pp.287, 2021 (SCI-Expanded, Scopus)
2021
20217. Hepatocyte Growth Factor and Insulin-like Growth Factor-1 Based Cellu-lar Therapies for Oxidative Stress Injury
Şahan Ö. B., Özcan A.
CURRENT STEM CELL RESEARCH & THERAPY
, vol.16, no.7, pp.771-791, 2021 (SCI-Expanded, Scopus)
2021
20218. Stem Cells under Stress
ÖZCAN A.
CURRENT STEM CELL RESEARCH & THERAPY
, vol.16, no.7, pp.753-754, 2021 (SCI-Expanded, Scopus)
2020
20209. IGF-1 and HGF Preconditioning of Bone Marrow Mesenchymal Stem Cells Reduced Proteinuria in Rat Focal Segmental Glomerulosclerosis Model
Sahan Ö. B., Onbaşılar İ., Güçer K. Ş., Kaymaz F. F., Atayar E., Özaltın F., et al.
CYTOTHERAPY
, vol.22, no.5, 2020 (SCI-Expanded, Scopus)
2019
201910. PKNOX2 expression and regulation in the bone marrow mesenchymal stem cells of Fanconi anemia patients and healthy donors.
Cagnan I., Cosgun E., Konu O., Uckan D., Gunel-Ozcan A.
Molecular biology reports
, vol.46, pp.669-678, 2019 (SCI-Expanded, Scopus)
2018
201811. Dual Effect of Glucocorticoid-Induced Tumor Necrosis Factor-Related Receptor Ligand Carrying Mesenchymal Stromal Cells on Small Cell Lung Cancer: A Preliminary in vitro Study
KÖPRÜ C. Z., Cagnan I., AKAR İ., ESENDAĞLI G., KORKUSUZ P., Gunel-Ozcan A.
CYTOTHERAPY
, vol.20, no.7, pp.930-940, 2018 (SCI-Expanded, Scopus)
2018
201812. Effect of IGF-1 and HGF induced bone marrow mesenchymal stem cells on focal segmental glomerulosclerosis in Sprague-Dawley rats: a pilot study
ŞAHAN Ö., KORKMAZ E., ONBAŞILAR İ., Gucer S., KAYMAZ F. F., ÖZALTIN F., et al.
FEBS OPEN BIO
, vol.8, pp.152, 2018 (SCI-Expanded, Scopus)
2018
201813. Effect of IGF1 and HGF Induced Bone Marrow Mesenchymal Stem Cells on Focal Segmental Glomerulosclerosis in SpragueDawley Rats: A pilot study
Şahan Ö. B., Korkmaz E., Onbaşılar İ., Güçer K. Ş., Kaymaz F. F., Özaltın F., et al.
FEBS OPEN BIO , vol.8, pp.152, 2018 (SCI-Expanded, Scopus)
2018
201814. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-beta 1 Production
CAGNAN I., GUNEL-OZCAN A., AERTS-KAYA F. S. F., Ameziane N., Kuskonmaz B., Dorsman J., et al.
STEM CELL REVIEWS AND REPORTS
, vol.14, no.3, pp.425-437, 2018 (SCI-Expanded, Scopus)
2017
201715. From Stem Cell Biology to The Treatment of Lung Diseases
Esendagli D., Gunel-Ozcan A.
CURRENT STEM CELL RESEARCH & THERAPY
, vol.12, no.6, pp.493-505, 2017 (SCI-Expanded, Scopus)
2017
201716. Stably expressed reference genes during differentiation of bone marrow-derived mesenchymal stromal cells
Cagnan I., Aerts Kaya F. S. F., Uckan D., Gunel Ozcan A.
TURKISH JOURNAL OF BIOLOGY
, vol.41, no.1, pp.88-97, 2017 (SCI-Expanded, Scopus, TRDizin)
2016
201617. Change in HOX gene expression by osteogenic differentiation capacity of human bone marrow derived mesenchymal stromal stem cells
Cagnan I., AERTS KAYA F., UCKAN D., ÖZCAN A. G.
Human Gene Therapy , vol.27, pp.69, 2016 (SCI-Expanded, Scopus)
2016
201618. Differentially expressed miRNAs in the G CSF primed donor mesenchymal stem cells
GÜNEL ÖZCAN A., SAHAN O. B., Cagnan I., ÇETİNKAYA F. D.
Febs Journal , vol.283, pp.95-96, 2016 (SCI-Expanded, Scopus)
2016
201619. 2015 Nobel Kimya Ödülü nün önemi DNA Onarımı ve Kanser
GÜNEL ÖZCAN A., Kansu E.
Herkese Bilim Teknoloji
, 2016 (Non Peer-Reviewed Journal)
2015
201520. Unmodified Mesenchymal Stem Cells do not support in vitro T and B Cell differentiation of Hematopoietic Stem Cells
PARİSA S., CEVHER İ., GÜNEL ÖZCAN A., ÇETİNKAYA F. D., AERTS KAYA F.
Human Gene Therapy
, vol.26, pp.90, 2015 (SCI-Expanded, Scopus)
2015
201521. Genome wide non coding RNA expression profile indicates upregulation of hsa miR 761 in the bone marrow mesenchymal stromal cells of Fanconi Anemia patients
Cagnan I., ÇETİNKAYA F. D., ÖZCAN A.
Human Gene Therapy , vol.26, pp.86-87, 2015 (SCI-Expanded, Scopus)
2014
201422. miRNA Expression Profiling in Mesenchymal Stromal Stem Cells Derived from G CSF Primed Bone Marrows
GÜNEL ÖZCAN A., Cagnan I., Kansu E., ÇETİNKAYA F. D.
Blood , vol.124, 2014 (SCI-Expanded, Scopus)
2014
201423. Gene expression of Notch receptors and ligands by plastic adherent and prospectively isolated MSCs
AYDIN G., AERTS KAYA F., Cagnan I., GUENEL OEZCAN A., ÇETİNKAYA F. D.
Human Gene Therapy , vol.25, pp.116, 2014 (SCI-Expanded, Scopus)
2014
201424. The frequency of Familial Mediterranean fever gene mutations and genotypes at Kirikkale and comparison with the mean of regional MEFV mutation frequency of Turkey
Kocakap D. B. S., Gunel-Ozcan A., Cabuk F., Ensari C.
MOLECULAR BIOLOGY REPORTS
, vol.41, no.3, pp.1419-1426, 2014 (SCI-Expanded, Scopus)
2013
201325. DIFFERENTIAL MIRNA EXPRESSION PROFILE OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS IN FANCONI ANEMIA PATIENTS AND HEALTHY DONORS
GÜNEL ÖZCAN A., Cagnan I., KONU KARAKAYALI Ö., AERTS KAYA F., KUŞKONMAZ B. B., ÇETİNKAYA F. D.
Experimental Hematology , vol.41, pp.61, 2013 (SCI-Expanded, Scopus)
2012
201226. Tenascin-R: Role in the central nervous system
Anlar B., Gunel-Ozcan A.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
, vol.44, no.9, pp.1385-1389, 2012 (SCI-Expanded, Scopus)
2009
200927. Hereditary haemochromatosis gene (HFE) H63D mutation shows an association with abnormal sperm motility
Gunel-Ozcan A., Basar M. M., Kisa U., Ankarali H. C.
MOLECULAR BIOLOGY REPORTS
, vol.36, no.7, pp.1709-1714, 2009 (SCI-Expanded, Scopus)
2009
200928. The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at KÄaut +/- rÄaut +/- kkale University in Turkey
Gunel-Ozcan A., Sayin D. B., Misirlioglu E. D., Guliter S., Yakaryilmaz F., Ensari C.
MOLECULAR BIOLOGY REPORTS
, vol.36, no.4, pp.757-760, 2009 (SCI-Expanded, Scopus)
2009
200929. Kritik Hastada Moleküler Biyoloji ve Genetik
Özcan A.
KATKI Pediatri dergisi , vol.31, no.2-3, pp.355-371, 2009 (Non Peer-Reviewed Journal)
2009
200930. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats
ESENDAĞLI G., Yilmaz G., CANPINAR H., Gunel-Ozcan A., Guc M. O., Guc D.
LABORATORY ANIMALS
, vol.43, no.1, pp.60-64, 2009 (SCI-Expanded, Scopus)
2009
200931. Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene
ESENDAĞLI G., CANPINAR H., Yilmaz G., Gunel-Ozcan A., Guc M. O., Kansu E., et al.
CANCER BIOLOGY & THERAPY
, vol.8, no.2, pp.136-142, 2009 (SCI-Expanded, Scopus)
2009
200932. Molecular and functional analysis of a novel recombinant clone of rat (Rattus norvegicus) CD40 ligand (CD40L) gene
ESENDAĞLI G., Gunel-Ozcan A., CANPINAR H., Guc D.
MOLECULAR BIOLOGY REPORTS
, vol.36, no.1, pp.83-89, 2009 (SCI-Expanded, Scopus)
2008
200833. Adhesion of beta1 integrin to fibronectin regulates CAM-DR phenotype via p21(WAF1/cip1) in HL60 acute myeloid leukemia (AML) cells
CANPINAR H., ESENDAĞLI G., Kansu E., Ozcan A. G., Guc D.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.38, no.2, pp.97-104, 2008 (SCI-Expanded, Scopus, TRDizin)
2006
200634. Salmonella typhimurium aroB encoding murine IL 18 or CD40L evaluation for gene therapy
AYDIN D., GÜNEL ÖZCAN A., MENAGER N., ESENDAĞLI G., GÜÇ M. O., HAYRAN K. M., et al.
Febs Journal
, vol.273, pp.49-50, 2006 (SCI-Expanded, Scopus)
2006
200635. HFE H63D mutation frequency shows an increase in Turkish women with breast cancer
Gunel-Ozcan A., ALYILMAZ-BEKMEZ S., GULER E., GUC D.
BMC CANCER
, vol.6, 2006 (SCI-Expanded, Scopus)
2003
200336. pTARGET vector carrying IL 18 or CD40L genes for attenuated Salmonella typhimurium mediated gene therapy
BEK D., ESENDAĞLI G., GÜNEL ÖZCAN A., GÜÇ D., GÜÇ M. O., Kansu E.
Blood , vol.102, pp.491, 2003 (SCI-Expanded, Scopus)
1998
199837. Expression of recombinant aroB-encoded dehydroquinate synthase from pathogenic microorganisms.
SKINNER M., Gunel-ozcan A., SHAFIQ M., Maskell D., Brown K.
BIOCHEMICAL SOCIETY TRANSACTIONS
, vol.26, no.3, 1998 (SCI-Expanded, Scopus)
1997
199738. Dehydroquinate synthase binds divalent and trivalent cations: Role of metal binding in catalysis.
SKINNER M., Gunel-Ozcan A., Moore J., Hawkins A., Brown K.
BIOCHEMICAL SOCIETY TRANSACTIONS
, vol.25, no.4, 1997 (SCI-Expanded, Scopus)
1997
199739. Salmonella typhimurium aroB mutants are attentuated in BALB/c mice
Gunel-Ozcan A., Brown K., Allen A., Maskell D.
MICROBIAL PATHOGENESIS
, vol.23, no.5, pp.311-316, 1997 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. The effects of intranasal treatment with mitochondria-targeted slow hydrogen sulfide releasing donor AP39 on bleomycin-induced pulmonary fibrosis in mice
Karaman Y., Büber E., Kurtulan O., Bayramzadeh ., Abohalaka ., Şahan Ö. B., et al.
European-Respiratory-Society Congress (ERS) EUROPEAN RESPIRATORY JOURNAL, Amsterdam, Netherlands, 27 September - 01 October 2025, vol.66, no.69, pp.5600, (Summary Text)
2025
20252. The role of hydrogen sulphide in TGF-β1-induced pulmonary fibrosis in human lung tissues
Kaya F., Abohalaka ., Karaman Y., Büber E., Kurtulan O., Uysal S., et al.
European-Respiratory-Society Congress (ERS) EUROPEAN RESPIRATORY JOURNAL, Amsterdam, Netherlands, 27 September - 01 October 2025, vol.66, no.868, pp.868, (Summary Text)
2025
20253. PDGF-DD and Imatinib shape MSC anti-fibrotic behavior through PDGFR-b modulation
Keleş M., Şahan Ö. B., Alişan A. B., Aerts Kaya F. S. F., Günel Özcan A.
49th FEBS Congress, , İstanbul, Turkey, 5 - 09 July 2025, vol.15, no.2, pp.33, (Summary Text)
2025
20254. Oncostatin M primes mesenchymal stem cells, modulating their migratory, secretory, and miRNA-regulatory behaviors in a manner that may promote fibrosis resolution
Alişan A. B., Şahan Ö. B., Keleş M., Alpdündar Bulut E., Günel Özcan A.
49th FEBS Congress, İstanbul, Turkey, 5 - 09 July 2025, vol.15, no.2, pp.91, (Summary Text)
2025
20255. Melatonin preconditioning enhances the anti- fibrotic potential of mesenchymal stem cells by modulating cytokine and miRNA profiles
Şahan Ö. B., Alişan A. B., Keleş M., Günel Özcan A.
49th FEBS Congress, İstanbul, Turkey, 5 - 09 July 2025, vol.15, no.2, pp.137-138, (Summary Text)
2025
20256. Deciphering the Regenerative Capacities of UC-MSCs and BM-MSCs: A Focus on Cytokine and Fibrosis-Related miRNA Profiles
Şahan Ö. B., Alişan A. B., Keleş M., Günel Özcan A.
ISSCR 2025, Kowloon, Hong Kong, 11 - 14 June 2025, pp.317-318, (Summary Text)
2024
20247. P119 Differential Expression Profile of miRNAs Indicates that HGF Priming Ameliorates Fibrosis Related miRNAs in Bone Marrow-derived Mesenchymal Stem Cells
Alişan A. B., Şahan Ö. B., Günel-Özcan A.
9 th International Congress of the Molecular Biology Association of Turkey, İzmir, Turkey, 12 - 14 September 2024, pp.160, (Summary Text)
2024
20248. Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice
Karaman Y., Büber E., Kurtulan O., Abohalaka R., Şahan Ö. B., Önder S. Ç., et al.
The ERS Congress 2024 , Vienna, Austria, 7 - 11 September 2024, vol.64, no.352, pp.352, (Summary Text)
2024
20249. PRIMING BONE MARROW MESENCHYMAL STEM CELLS WITH HEPATOCYTE GROWTH FACTOR (HGF-MSC) AMELIORATES BLEOMYCİN-INDUCED PULMONARY FIBROSIS IN MICE
Şahan Ö. B., Karaman Y., Büber E., Kurtulan O., Abohalaka R., Önder S. Ç., et al.
ISSCR 2024, Hamburg, Germany, 10 - 13 July 2024, pp.660, (Summary Text)
2024
202410. A new CRISPR-mediated Apc Knockout Allele leads to Pyloric Gland Adenoma-like Gastric Polyps in the Mice with C57BL/6; FVB/N Mixed Background
Uzun S., Özcan Ö., Gök A., Işık A., Bakır S., Günel-Özcan A., et al.
The First CRISPR Medicine Conference, Copenhagen Denmark, April 23-25, 2024 (virtual event April 22), Kobenhavn, Denmark, 23 - 25 April 2024, pp.92, (Summary Text)
2021
202111. PS-250“Kemik iliği mezenkimal kök hücre yaşlanmasında PKNOX2 transkripsiyon faktörü NF- κB/p65’e eşlik ediyor olabilir
Koçak E., Şahan Ö. B., Çetinkaya F. D., Günel-Özcan A.
17. Tıbbi Biyoloji ve Genetik Kongresi , İstanbul, Turkey, 28 - 31 October 2021, pp.250, (Summary Text)
2021
202112. P371“PKNOX2 can be a new player in NF-κB/p65 signaling in bone marrow mesenchymal stem cell senescence
Koçak E., Şahan Ö. B., Çetinkaya F. D., Günel-Özcan A.
European Society of Gene and Cell Therapy (ESGCT) Collaborative Virtual Congress, Brussels, Belgium, 19 - 22 October 2021, pp.371, (Summary Text)
2021
202113. Repair of Griscelli Type 2 mesenchymal stem cells with a lentiviral vector carrying RAB27Aco
Erol Ö. D., Şeker M. E., Pervin B., Van Til N. P., Günel_Özcan A., Kocaefe Y. Ç., et al.
İstiniye Üniversitesi Kök Hücre ve Doku Mühendisliği Sempozyumu, İstanbul, Turkey, 27 - 28 February 2021, (Summary Text)
2019
201914. OVCAR-3 adenokarsinoma over kanseri hücre hattında BMP-7 susturulması sonrası BMP-2, ZEB2 ve integrin α5-β1 ifadelerinin değerlendirilmesi
Bahador Zırh E., Şahan Ö. B., Zeybek N. D., Özcan A.
24. ULUSAL ELEKTRON MİKROSKOPİ KONGRESİ, Edirne, Turkey, 24 - 26 April 2019, pp.179, (Summary Text)
2018
201815. PKNOX2 proteomics reveals novel interactions with ATM and RPS3A in bone marrow-derived mesenchymal stem cells
Günel-Özcan A., Ayhan N., Şahan Ö. B., Çağnan I., Warasnhe K., Çetinkaya F. D.
EMBO Workshop- RNA and genome maintenance Cooperation and conflict management, Mainz, Germany, 10 - 13 October 2018, pp.89, (Summary Text)
2018
201816. Effect of IGF¬1 and HGF Induced Bone Marrow Mesenchymal Stem Cells on Focal Segmental Glomerulosclerosis in Sprague¬Dawley Rats: A pilot study
Sahan Ö. B., Korkmaz E., Onbaşılar İ., Güçer K. Ş., Kaymaz F. F., Özaltın F., et al.
43rd Febs Congress, Praha, Czech Republic, 7 - 12 July 2018, (Summary Text)
2018
201817. Naif ve İndüklenmiş Mezenkimal Kök Hücrelerin Fokal Segmental Glomeruloskleroz Üzerine Etkisinin Sprague-Dawley Modeli Üzerinde İncelenmesi
Şahan Ö. B., Korkmaz E., Onbaşılar İ., Güçer K. Ş., Kaymaz F. F., Özaltın F., et al.
4. Klinik İmmunoloji Kongresi, Antalya, Turkey, 11 - 14 April 2018, pp.65, (Summary Text)
2016
201618. High PKNOX2 level of mesenchymal stem cells prompts hematopoetic stem cell differentiation towards myeloid lineages in co-culture experiments
Cagnan I., Aertskaya F., Uckan D., Günel-Özcan A.
2nd International Conference on Stem Cells and Cancer, Antalya, Turkey, 15 November 2016 - 16 January 2018, (Summary Text)
2017
201719. TGF-b1 production by bone marrow mesenchymal stem cells of FANCD2 differs from other Fanconi Anemia Complemetation Groups
Cagnan I., Günel-Özcan A., Aertskaya F., Ameziane N., Kuskonmaz B. B., Dorsman J., et al.
59th ASH Annual Meeting and Exposition (December 9-12), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)
2017
201720. TGF-beta 1 Production By Bone Marrow Mesenchymal Stem Cells of FANCD2 Differs from Other Fanconi Anemia Complementation Groups
Cagnan I., Gunel-Ozcan A., Aerts-Kaya F. S. F., Ameziane N., Kuskonmaz B., Dorsman J., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)
2017
201721. PKNOX2 regulated by TGFbeta is a new candidate to explain bone marrow failure in Fanconi anemis
Cagnan I., AERTSKAYA F., COSGUN E., KONU KARAKAYALI Ö., ÇETİNKAYA F. D., ÖZCAN A.
46th ISEH Annual Scientific Meeting 2017 (24-27 Ağustos) Frankfurt, Almanya, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.136, (Summary Text)
2017
201722. Development and characterization of iPS cell lines from a patient with Griscelli type 2 disease
GUNEY G., PERVİN B., SAHAN Ö. B., ÇETİNKAYA F. D., ÖZCAN A., SCHAMBACH A., et al.
46th ISEH annual scientific meetings 2017 (24-28 Ağustos)Frankfurt, Almanya, Frankfurt, Germany, 24 - 27 August 2017, (Summary Text)
2017
201723. PKNOX2 regulated by TGFbeta is a new candidate to explain bone marrow failure in Fanconi Anemia.
Cagnan I., Aerts Kaya F. S. F., Coşgun E., Konu Karakayalı Ö., Kuşkonmaz B. B., Çetinkaya F. D., et al.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.136, (Summary Text)
2017
201724. Development and characterization of iPS cell lines from a patient with Griscelli type 2 disease.
Güney E. G., Pervin b., ŞAHAN Ö. B., ÇETİNKAYA F. D., ÖZCAN A., Schambach A., et al.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.135, (Summary Text)
2016
201625. Change in HOX gene expression by osteogenic differentiation capacity of human bone marrow derived mesenchymal stromal/stem cells
Cagnan I., Aerts-Kaya F. S. F., Uckan D., ÖZCAN A.
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, Italy, 18 - 21 October 2016, vol.27, (Summary Text)
2016
201626. PBX/Knotted 1 Homeobox 2 is an activator and a downstream target of transforming growth factor beta-1
Cagnan I., Cetinkaya D. U., ÖZCAN A.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.59-60, (Summary Text)
2015
201527. Mesenchymal stem cells induce proliferation of NCI-H82 small cell lung cancer
KOPRU C. Z., CAGNAN I., Akar-Soycan I., ESENDAĞLI G., KORKUSUZ P., ÖZCAN A.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text)
2015
201528. pCR3::GITRL transfected MSCs induce apoptotic cell death and SIVA1 expression in SCLC-21H lung cancer cell line
KOPRU C. Z., KORKUSUZ P., CAGNAN I., Akar-Soycan I., ESENDAĞLI G., ÖZCAN A.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text)
2015
201529. Genome-wide non-coding RNA expression profile indicates upregulation of hsa-miR-761 in the bone marrow mesenchymal stromal cells of Fanconi Anemia patients
Cagnan I., Uckan D., ÖZCAN A.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text)
2015
201530. Nanopartiküller ile işaretli pGITRL aktarılmış mezenkimal kök hücrelerin küçük hücreli akciğer kanseri hücreleriyle görüntülenmesi
KÖPRÜ C. Z., GÜNEL ÖZCAN A., Cagnan I., AKAR SOYCAN İ., ESENDAĞLI G., KORKUSUZ P.
22.nci Elektron Mikroskopi Kongresi (EMK 2015), İstanbul, Turkey, 2 - 04 September 2015
2015
201531. Use of Mesenchymal Stem Cells as Feeder Cells to Support In Vitro T- and B-Cell Differentiation of Hematopoietic Stem Cells
Cevher İ., Sharafi P., Aydın G., ÖZCAN A., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
V. Int congress of Mol Med 2015, İzmir, Turkey, 20 - 22 May 2015, pp.182, (Summary Text)
2015
201532. KOAH da Kök Hücre Tedavisi
GÜNEL ÖZCAN A.
Türk Toraks Derneği 18. Yıllık Kongresi, Turkey, 1 - 05 April 2015
2015
201533. Gene expression of Notch receptors and ligands by human Mesenchymal Stem Cells from different tissues
Aydin G., Aerts-Kaydz F., ÖZCAN A., Uckan-Cetinkaya D.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text)
2014
201434. miRNA Expression Profiling in Mesenchymal Stromal/Stem Cells Derived from G-CSF Primed Bone Marrows
Özcan A., Cagnan I., Kansu E., Uckan D.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text)
2014
201435. Fankoni Anemili Hastaların Kemik İliği Mezenkimal Kök Hücrelerinde PREP2 Gen İfadesi Donörlere Oranla Düşüş Göstermektedir.
ÇAĞNAN I., Coşgun E., KONU KARAKAYALI Ö., AERTS KAYA F. S. F., KUŞKONMAZ B. B., ÖZCAN A.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, (Summary Text)
2013
201336. Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.
Cagnan I., KONU KARAKAYALI Ö., AERTS KAYA F. S. F., Kuskonmaz B. B., ÇETİNKAYA F. D., ÖZCAN A.
ISSCR 2013, 15 - 18 September 2013, pp.37-38, (Summary Text)
2013
201337. DIFFERENTIAL MIRNA EXPRESSION PROFILE OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS IN FANCONI ANEMIA PATIENTS AND HEALTHY DONORS
Özcan A., Cagnan I., Konu O., Kaya F. A., Kuşkonmaz B. B., Uckan D.
42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), Vienna, Austria, 22 - 25 August 2013, vol.41, (Summary Text)
2013
201338. Interaction of mesenchymal stem and HeLa cells with gold nanoparticles
TAN G., SAĞLAM N., KÖPRÜ C. Z., KÖSE S., ONUR M. A., Ozcan A. G., et al.
European Biotechnology Congress, Bratislava, Slovakia, 16 - 18 May 2013, vol.24, (Summary Text)
2012
201239. HOX-TALE genes show highly conserved yet heterogeneous expression profiles among fanconi anemia patients and healthy donors
ÇAĞNAN I., KONU KARAKAYALI Ö., AERTS KAYA F. S. F., KUŞKONMAZ B. B., ÇETİNKAYA F. D., ÖZCAN A.
HOX and TALE Transcription Factors in Development and Disease, Madrid, Spain, 28 November 2012 - 01 December 2010, pp.53, (Summary Text)
2012
201240. Expression of HOX genes in the bone marrow derived mesenchymal stromal/stem cells from Fanconi anemia patients changes following bone marrow transplantation.
ÖZCAN A., Cagnan I., KUŞKONMAZ B. B., AERTS KAYA F. S. F., ÇETİNKAYA F. D.
ISSCR annual meeting 2012, 13 - 16 June 2012, vol.1, pp.126, (Summary Text)
2011
201141. Relative gene expression analysis shows increased mRNA levels of HoxB7 and HoxA10 and decreased mRNA levels of Pbx1 in the bone marrow derived mesenchymal progenitors from Fanconi anemia patients
Ozcan A., Cagnan I., Kuskonmaz B. B., Cetinkaya D. U.
European Biotechnology Congress, İstanbul, Turkey, 28 September - 01 October 2011, vol.22, (Summary Text)
2010
201042. Hastalıkta Ve Sağlıkta Mezenkimal Kök Hücrelerin MIRNA İfadeleri
ÖZCAN A., Kılıç E., AERTS KAYA F. S. F., ÇETİN M., ÇETİNKAYA F. D.
1. Uluslararası Katılımlı Kök Hücre Sempozyumu 2010, Samsun, Turkey, 29 September - 01 October 2010, pp.59, (Summary Text)
2009
200943. Osteopetrosis hastalarının kemik iliği kaynaklı mezenkimal kök hücrelerinin adipojenik farklılaşmalarında rol oynayan miRNA ekspresyon profilinin saptanması.
ÖZCAN A., Kılıç E., AERTS KAYA F. S. F., ÇETİN M., ÇETİNKAYA F. D.
XI. Ulusal Tıbbi Genetik ve Biyolojisi Kongresi 2009, Turkey, 28 - 31 October 2009, (Summary Text)
2009
200944. Kök Hücre Genetik Modifikasyonlarının Biyogüvenlik ve Risk Değerlendirmesi
ÖZCAN A., AERTS KAYA F. S. F., ÇETİNKAYA F. D.
1. Ulusal Hücresel Tedavi ve Rejeneratif Tıp Kongresi, Kapadokya, Turkey, 5 - 08 March 2009, pp.103, (Summary Text)
2003
200345. pTARGET vector carrying IL-18 or CD40L genes for attenuated Salmonella typhimurium mediated gene therapy.
Bek D., Esendagli G., Gunel-Ozcan A., Guc D., Guc M., Kansu E.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)
Books
2021
20211. Preface
Özcan A. (Editor)
in: Türkiye Klinikleri Tıbbi Genetik Özel Konular- Kök Hücre ve Rejeneratif Tıp, Ayşen Günel-Özcan, Editor, Türkiye Klinikleri Yayınevi, Ankara, 2021
2021
20212. Stem Cell Genomic Stability, Cell Fate and Regeneration
Özcan A.
in: Türkiye Klinikleri Tıbbi Genetik Özel Konular- Kök Hücre ve Rejeneratif Tıp, Ayşen Günel-Özcan, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.1-9, 2021
2021
20213. Empowered Mesenchymal Stem Cells with Enhanced Regenerative Capacity
Şahan Ö. B., Özcan A.
in: Kök Hücre ve Rejeneratif Tıp - 2021, Prof. Dr. Ayşen Günel Özcan, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.26-33, 2021
2008
20084. Bölüm 2 Genetik Hastalıklar- Konu 13 Gen Tedavisinin Temel Prensipleri ve Klinik Uygulamaları
Özcan A.
in: İç Hastalıkları , Genel Editör: Prof. Dr. Çetin Erol Bölüm Editörü,Bölüm editörü: Prof. Dr. Işık Bökesoy, Editor, Nobel Yayın Dağıtım, Ankara, pp.103-117, 2008
Funded Projects
2025 - Present
2025 - PresentTranslasyonel preklinik modeller ile pulmoner fibrosis için yeni tedavi yaklaşımlarının geliştirilmesi
Project Supported by Higher Education Institutions , BAP Research Project
BOZKURT T. E. (Executive), ÖZCAN A., NEMUTLU E., KARAMAN Y., ÖNDER S. Ç., UYSAL S., et al.
2023 - 2025
2023 - 2025Mezenkimal kök hücrelerde ön-koşullandırma ajanlarının antifibrotik etkilerinin miRNA ekspresyon profili ile değerlendirilmesi
Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
Günel Özcan A. (Executive), Şahan Ö. B.
2022 - 2024
2022 - 2024Hepatosit Büyüme Faktörü HGF İle Lisanslanmış Mezenkimal Kök Hücrelerde Antifibrotik miRNA İfade Düzeyleri
Project Supported by Higher Education Institutions , BAP MSc
ÖZCAN A. (Executive), ALİŞAN A. B., ŞAHAN Ö. B.
2021 - 2023
2021 - 2023Kemik İliği Mezenkimal Kök Hücrelerinde p53 Yolağı Regülasyonunda PKNOX2 ve Etkileşimlerinin Araştırılması
Project Supported by Higher Education Institutions , BAP Other
ÖZCAN A. (Executive), Keleş M., ÇETİNKAYA F. D., ŞAHAN Ö. B.
2021 - 2023
2021 - 2023Effect of Reduced Bdnf Expression on Intestinal Tumorigenesis in Apc Mutant Mouse Model
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
(Project Abstract)
Akyol A. (Executive), Onbaşılar İ., Özcan A., Güner G., Yılmaz E.
2019 - 2022
2019 - 2022Mezenkimal Kök Hücre Yaşlanmasında P65 ve PKNOX2 Etkileşimlerinin İncelenmesi
Project Supported by Higher Education Institutions , BAP Other
ÖZCAN A. (Executive), KOÇAK E., ÇETİNKAYA F. D., ŞAHAN Ö. B.
2017 - 2019
2017 - 2019
OVER KANSERLERİNDE BMP7 ve BMP2'NİN İNVAZYON VE METASTAZDAKİ ETKİSİ
Project Supported by Higher Education Institutions , BAP Research Project
ZEYBEK N. D. (Executive), TAŞAR G. E., ÖZCAN A., DOLGUN N. A., GÖK M., Bahador E., et al.
2017 - 2019
2017 - 2019Dental Pulpa Ve Kemik Iliği Kaynaklı Mezenkimal Kök Hücrelerin Osteojenik Farklılaşmasında Hypericum Perforatum Sarı Kantaron Ekstraktının Adrenerjik Reseptörler Ve Epigenetik Faktör Ezh2 Ekspresyonuna Olan Etkisinin Araştırılması TÜBİTAK 216S318
TUBITAK Project , 3501 - National Young Researcher Career Development Program
Özcan A.
2016 - 2019
2016 - 2019Podosit Kimyasal Hasar Modeli Üzerine İndüklenmiş Mezenkimal Kök Hücrelerin Etkisi
Project Supported by Higher Education Institutions , BAP Other
ÖZCAN A. (Executive), GÜÇER K. Ş., ONBAŞILAR İ., ŞAHAN Ö. B., KORKMAZ E.
2015 - 2018
2015 - 2018Fankoni Anemisi Kemik İliği Mezenkimal Kök Hücrelerinde HOX ve TALE Transkripsiyon Faktörleri Gen İfadeleri ve Protein Etkileşimleri TUBITAK 1001 214Z033
TUBITAK Project
ÖZCAN A. (Executive), ŞAHAN Ö. B.
2016 - 2017
2016 - 2017Hacettepe Üniversitesi Ar Ge Strateji Belgesi Rejeneratif ve Restoratif Tıp
TUBITAK Project , 1000 - Üniversitelerin Araştırma ve Geliştirme Potansiyelinin Arttırılmasına Yönelik Destek Programı
Çetinkaya F. D., Çelebi Saltık B., Vargel İ. (Executive), Okur F. V., Korkusuz P., Özcan A.
2016 - 2016
2016 - 2016Avrupa Gen ve Hücresel Tedaviler Derneği (ESGCT) ve Uluslararası kök hücre araştırma derneği (ISSCR) birleşik Kongresi 2016 Floransa
Project Supported by Higher Education Institutions , BAP Other
ÖZCAN A. (Executive)
2015 - 2016
2015 - 2016Kök Hücre Günü 2015
Project Supported by Higher Education Institutions , BAP Other
AERTS KAYA F. S. F. (Executive), ÇETİNKAYA F. D., ÖZCAN A., ÇELEBİ SALTIK B.
2015 - 2016
2015 - 2016IN VIVO GCSF UYGULAMASININ SAĞLIKLI DONORLERİN KEMİK İLİĞİ KAYNAKLI MEZENKİMAL KÖK HÜCRE miRNA İFADELERİ ÜZERİNE ETKİSİ
Project Supported by Higher Education Institutions , BAP Other
ÖZCAN A. (Executive), ÇETİNKAYA F. D., ŞAHAN Ö. B.
2010 - 2016
2010 - 2016Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency
EU Framework Program Project
ÖZCAN A.
2015 - 2015
2015 - 2015ESGCT and FSGT Collaborative Congress Helsinki Finlandiya kongre katılım
Project Supported by Higher Education Institutions , BAP Other
ÖZCAN A. (Executive)
2010 - 2014
2010 - 2014HOX/TALE genlerinin Kemik İliği Nakli Yapılan Fanconi Anemisi Hastalarının Kemik İliği Mezenkimal Kök Hücrelerindeki Ekspresyon Profillerinin Saptanması ve HOX/TALE Regülasynunda Rol oynayan Tüm Genom miRNA Ekspresyon Mikroarray Korelasyonlarının Araştırılmas
EU Supported Other Project
ÖZCAN A. (Executive)
2006 - 2010
2006 - 2010PEDI-STEM Kök hücre araştırma, geliştirme ve hücresel tedavi merkezi oluşturma
CB Strateji ve Bütçe Başkanlığı (Kalkınma Bakanlığı) Projesi
ÖZCAN A.
2004 - 2005
2004 - 2005Kimyasal karsinojenez ile oluşturulmuş rat meme adenokarsinom hücrelerinde CD40L geninin klonlanması ve ex-vivo immün yanıtın karakterizasyonu
Project Supported by Other Private Institutions
ÖZCAN A. (Executive)
Patent
2024
2024ApcΔ750 Mutant Fare Bağırsak Tümör Modeli
Patent
Registered / Approved, The Invention Registration Number: 2022/010652 , Standard Registration
Memberships and Roles in Scientific Organizations
2018 - Present
2018 - PresentTürkiye Solunum Araştırmaları Derneği
Member
2017 - Present
2017 - PresentISEH
Member
2014 - Present
2014 - PresentESGCT
Member
2012 - Present
2012 - PresentISSCR
Member
2010 - Present
2010 - PresentTıbbi Biyoloji ve Genetik
Member
2000 - Present
2000 - PresentTıbbi Genetik
Member
Awards
October 2018
October 2018“Prof. Dr. Meliha Terzioğlu Bilim Ödülü”
Türkiye Solunum Araştırmaları Derneği
March 2014
March 20141. Uluslararası Katılımlı Kök Hücre ve Hücresel Tedaviler Kongresi en iyi ikinci poster ödülü
Kök Hücre ve Hücresel Tedaviler Derneği
October 2006
October 2006
1. Multidisipliner Kanser Araştırmaları Sempozyumu En iyi Poster Ödülü 2006
MOKAD
October 2005
October 20051. Moleküler Tıp Kongresi en iyi ikinci poster ödülü
Moleküler Tıp Derneği
October 2003
October 200313th Balkan Biochemical Biophysical Days & Meeting on Metabolic Disorders Poster Mansion Award
Türk Biyokimya Derneği
Invited Talks
October 2025
October 2025Üçüncü Milenyumda Yeni Tıp Çağı: Gen Mühendisliği ve Genomik Tedaviler. Yenilikçi Yaklaşımlar ile Kök Hücre Teknolojileri Çalıştayı, Hacettepe Üniversitesi, Ekim 2025
Workshop
Hacettepe University-Turkey
September 2023
September 2023Adenoassosiye Virüs Tabanlı Gen Tedavilerinde Güncel Gelişmeler ve Rekombinant AAV'lerde Yeni Ufuklar, Yeni Nesil Gen ve Hücre Tedavi Uygulamaları Paneli - 1 30 Eylül 2023 BioTürkiye Uluslararası BiyoTeknoloji Kongresi 28-30 Eylül 2023, Osmanlı Külliyesi İstanbul
Conference
BioTürkiye International Biotechnology Congress-2023-Turkey
November 2022
November 2022Köklere dönüyor muyuz? İPF, KOAH ve ARDS’de kök hücre tedavisi 6 Kasım 2022 TÜSAD 44. Uluslararası Katılımlı Yıllık Kongresi - "SOLUNUM 2022"
Conference
Türkiye Solunum Araştırmaları Derneği -Turkey
November 2019
November 2019‘Rekombinant Hücre ve GenTeknolojileri: Viral Vektörler’ 28 Kasım 2019 ‘ileri Tedavi Tıbbi Ürünleri’ II. Farmasötik Biyoteknoloji Çalıştayı
Workshop
Farmasötik Biyoteknoloji Derneği-Turkey
February 2019
February 2019Kanser Tedavisinde Kök Hücreler, IV. Hacettepe Biyoloji ve Uygulamaları Kongresi (4-6 Şubat 2019)
Conference
Hacettepe Üniversitesi-Turkey
August 2017
August 2017Adult Stem Cells and Cancer: Is There a Link? 21 Ağustos 2017 SYNAPSIST’17 Summer School WITH A NEW TOPIC: CANCER, Koç University August 2017
Conference
Koc University-Turkey
April 2017
April 2017Genom Çağında Moleküler Kanser Biyolojisi, Carcinos ‘Kanser’ Sempozyumu 9 Nisan 2017
Conference
Gazi Üniversitesi-Turkey
April 2017
April 2017Gen Aktarım Platformu Olarak Mezenkimal Kök Hücreler, İstanbul Üniversitesi 2. Kök Hücre ve Uygulamaları Sempozyumu Cemil Birsel Oditoryumu 29.04.2017
Conference
İstanbul Üniversitesi-Turkey
March 2017
March 2017Dünden Bugüne Kök Hücre Araştırmaları, Uşak Üniversitesi Biyolojik Bilimler ve Biyoteknoloji Topluluğu Konferansları-I 10 Mart 2017
Conference
Uşak Üniversitesi-Turkey
November 2016
November 2016Fanconi anemisinde Kemik iliği mezenkimal kök hücrelerinin HOX/TALE kimliği ve Fizyopatolojik önemi’ . Hacettepe Üniversitesi ‘Kök Hücre Günü 2016'
Conference
Hacettepe Üniversitesi-Turkey
February 2016
February 2016Kök Hücreler ile İmmunomodülasyon, 3 Şubat 2016 Hitit Üniversitesi Çorum
Conference
Hitit Üniversitesi-Turkey
April 2015
April 2015KOAH da Kök Hücre Tedavisi, Türk Toraks Derneği 18. Yıllık Kongresi
Conference
Türk Toraks Derneği-Turkey
February 2014
February 2014Doku Kimliğinin Belirlenmesinde HOX Kodları ve Rejeneratif Tıpta Önemi, 4. Ulusal Hücresel Tedavi ve Rejeneratif Tıp Kongresi
Conference
Ulusal Hücresel Tedavi ve Rejeneratif Tıp Derneği-Turkey
October 2013
October 2013HOX-TALE expression patterns in Fanconi anemia, Meeting for HOX and TALE TFs in Development and Disease (COST Action BM0805 Meeting), 04.10.2013, Egmond aan Zee
Conference
COST ACTION BM0805 Meeting-Netherlands
September 2011
September 2011HOX-TALE expression in bone marrow derived mesenchymal stromal cells of Fanconi anemia patients 30.09. 2011 COST BM0805 Meeting, Carry-Le-Rouet. Marsilya
Conference
COST BM0805 Meeting-France
September 2010
September 2010Hastalıkta ve Sağlıkta Mezenkimal Kök Hücrelerin miRNA ifadeleri, 1. Uluslarası katılımlı kök hücre sempozyumu, Samsun
Conference
1. Uluslarası katılımlı Kök Hücre Sempozyumu, Samsun-Turkey
July 1996
July 1996Dehydroquinate synthase as a possible target for developing new antimicrobial agents, IUMS Congresses 96, 8th International Congress of Bacteriology and Applied Microbiology Division
Conference
IUMS -Israel
Scholarships
2003 - 2003
2003 - 2003EMBO SAGE Course Amsterdam
Other International Organizations
1994 - 1997
1994 - 1997